Daniel Allar

""



Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

LATEST ARTICLES BY THIS AUTHOR

Severe mitral stenosis tied to worse outcomes post-TAVR
Informal caregiving costs for CVD in US projected to skyrocket to $128B by 2035
Novel cardiac MRI technique quicker, more comfortable for patients
Timing of follow-up visits after heart failure doesn’t improve medication adherence
TAVR better, cheaper than SAVR for patients with COPD
Steep drops in wealth tied to 50% increase in death risk
Money-back guarantees fail to boost cost-effectiveness of PCSK9 inhibitors
FDA approves septal occluder for PFO closure to prevent recurrent stroke
Genetic testing to inform antiplatelet choice reduces adverse events post-PCI
Abiomed adds optical sensor, SmartAssist technology to FDA approval for Impella CP